Post AHSCT (Autologous Hematopoietic Stem Cell Transplantation) management for patients with systemic sclerosis: a prospective, non-interventional approach across Europe (NISSC-2)

Type d'étude:

Non-interventional Prospective Studies

Numéro de l'étude:

8410-025

Type de traitement à base de cellules souches:

Autologous

Maladies:

Titre court:

NISSc-2

Objectif principal:

To survey different practices of EBMT centres for post-AHSCT management for SSC patients

Principaux critères d'inclusion:

Autologous HSCT
Age above 18 years at time of autologous HSCT.
First AHSCT for a diagnosis of progressive systemic sclerosis according to 2013 EULAR-ACR criteria

Pays:

Investigateur principal:

Pr Dominique Farge

Coordinateur EBMT de l'étude:

Manuela Badoglio

E-mail du coordinateur de l'étude:

manuela.badoglio@upmc.fr